https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-27 / J. Clin. Oncol. 2004 Nov;22(21):4272-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-27 / J. Clin. Oncol. 2004 Nov;22(21):4272-812004-09-27 00:00:002020-06-23 09:41:00Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-01 / Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004 Sep;4(3):245-51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-01 / Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004 Sep;4(3):245-512004-09-01 00:00:002019-02-15 08:53:34Dendritic cell-based immunotherapy in thyroid malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-01 / Ceska Gynekol 2004 Sep;69(5):372-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-01 / Ceska Gynekol 2004 Sep;69(5):372-52004-09-01 00:00:002004-09-01 00:00:00[Immunotherapy–perspectives in therapy of ovarian carcinomas]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-59
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-09-01 / Int J Hyperthermia 2004 Sep;20(6):647-592004-09-01 00:00:002004-09-01 00:00:00A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-23 / BMC Cancer 2004 Aug;4:53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-23 / BMC Cancer 2004 Aug;4:532004-08-23 00:00:002004-08-23 00:00:00The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-262004-08-15 00:00:002019-02-15 08:47:00Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-62004-08-05 00:00:002019-02-15 08:48:24Therapeutic cancer vaccines: using unique antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-92004-08-01 00:00:002019-02-15 08:37:49Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-902004-08-01 00:00:002019-02-15 08:37:50Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / Ai Zheng 2004 Aug;23(8):910-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / Ai Zheng 2004 Aug;23(8):910-32004-08-01 00:00:002019-02-15 09:20:00[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]
